Conversion Price Adjustment Due to Stock Consolidation
-
1st CB: conversion price from KRW 886 to 4,430; convertible shares from 4,514,672 to 902,934
-
2nd CB: conversion price from KRW 924 to 4,620; convertible shares from 2,164,502 to 432,900
-
Reason: stock consolidation (5→1, effective date 2026-04-25)
-
Adjustment applied automatically per bond terms; no separate board resolution
KOSDAQ Filing Information
-
Filing: Adjustment of Conversion Price (1st Series, 2nd Series)
-
Company: Poongjeon Pharmacy (298060)
-
Submission: Poongjeon Pharmacy Co., Ltd.
-
Receipt: 04-27-2026
-
Under KRX KOSDAQ Market Division